COUP-TFII is a central nuclear hormone receptor that tightly regulates the expression of numerous target lipid metabolism genes in vertebrates. However, it remains unclear how COUP-TFII itself is transcriptionally controlled since studies with its promoter and upstream region fail to recapitulate the geneÕs liver expression. In an attempt to identify liver enhancers in the vicinity of COUP-TFII, we employed a comparative genomic approach. Initial comparisons between humans and mice of the 3470-kb gene-poor region surrounding COUP-TFII revealed 2023 conserved noncoding elements. To prioritize a subset of these elements for functional studies, we performed further genomic comparisons with the orthologous pufferfish (Fugu rubripes) locus and uncovered two anciently conserved noncoding sequences (CNS) upstream of COUP-TFII (CNS62kb and CNS-66kb). Testing these two elements using reporter constructs in liver cells (HepG2) revealed that CNS-66kb, but not CNS-62kb, yielded robust in vitro enhancer activity. In addition, an in vivo reporter assay using naked DNA transfer with CNS-66kb linked to luciferase displayed strong reproducible liver expression in adult mice, further supporting its role as a liver enhancer. Together, these studies further support the utility of comparative genomics to uncover gene regulatory sequences based on evolutionary conservation and provide the substrates to better understand the regulation and expression of COUP-TFII.
COUP-TFII is a central nuclear hormone receptor that tightly regulates the expression of numerous target lipid metabolism genes in vertebrates. However, it remains unclear how COUP-TFII itself is transcriptionally controlled since studies with its promoter and upstream region fail to recapitulate the geneÕs liver expression. In an attempt to identify liver enhancers in the vicinity of COUP-TFII, we employed a comparative genomic approach. Initial comparisons between humans and mice of the 3470-kb gene-poor region surrounding COUP-TFII revealed 2023 conserved noncoding elements. To prioritize a subset of these elements for functional studies, we performed further genomic comparisons with the orthologous pufferfish (Fugu rubripes) locus and uncovered two anciently conserved noncoding sequences (CNS) upstream of COUP-TFII (CNS62kb and CNS-66kb). Testing these two elements using reporter constructs in liver cells (HepG2) revealed that CNS-66kb, but not CNS-62kb, yielded robust in vitro enhancer activity. In addition, an in vivo reporter assay using naked DNA transfer with CNS-66kb linked to luciferase displayed strong reproducible liver expression in adult mice, further supporting its role as a liver enhancer. Together, these studies further support the utility of comparative genomics to uncover gene regulatory sequences based on evolutionary conservation and provide the substrates to better understand the regulation and expression of COUP-TFII. Specifically, COUP-TFII is expressed in restricted regions of the central nervous system during embryonic development, as well as in mesenchymal tissue of many organs and in the developing eyes (Qiu et al. 1994; Qiu et al. 1995) . However, the cisregulatory sequences responsible for this regulation remain partially defined. Using a 4.2-kb mouse DNA fragment of the COUP-TFII promoter plus the upstream interval, Zhang et al. (2002) tested the regulatory properties of this sequence in transgenic mouse embryos. At embryonic day 9, expression was found in the notochord, the ventral neural tube, and the gut endoderm, while at embryonic day 15.5 COUP-TFII expression was found in numerous tissues derived from endoderm, including lung, pancreas, stomach, intestine, bladder, esophagus, and thyroid. However, no expression was found in liver despite COUP-TFIIÕs know expression in this tissue at this embryonic developmental stage. These data suggested the existence of a distant COUP-TFII liver enhancer which we set out to identify in this study. Based on the availability of several vertebrate genome sequences and the success of comparative genomics to identify functional sequences ( , we used an evolutionary conservation filter to identify conserved noncoding sequences in vicinity of COUP-TFII and subsequently tested these sequences for liver enhancer properties.
Material and methods
Comparative genomics and human COUP-TFII plasmid constructs. Human, mouse, and fugu sequences were obtained from the UCSC genome browser (http://genome.ucsc.edu/) and genomic sequence comparisons were performed using VISTA (Mayor et al. 2000) . We cloned the conserved noncoding human sequences (CNS-62kb and CNS66kb) upstream of the pGL3-promoter vector (Promega) using the following primers: CNS-66kb-F: CCTCTGGGCACACGGACTCT; CNS-66kb-R: CT AATAAAGTCCAAGGGTC; and CNS-62kb-F:ATG TTTGTGGCGTTTCTTCC; CNS-62kb-R:TAACTC AAGCCTCAGAAAGC.
Reporter gene transfection studies: luciferase assays. Human HepG2 hepatoma cells (ATCC HB8065) were grown in DulbeccoÕs Modified EagleÕs Medium (DMEM) (GibcoBRL) supplemented with 10% fetal bovine serum (FBS) (Hyclone), 2 mM glutamine, 0.1 mM nonessential amino acids, and 1 mM sodium pyruvate. Cells were grown in 6-well plates and transfected using Fugene (Roche Molecular Biochemicals) following the manufacturerÕs protocol. Transfections were carried out in triplicates. Briefly, 1 lg of each assayed plasmid and 0.25 lg of pSEAP2-control plasmid (BD Biosciences) and 0.25 lg were mixed with 6 ll Fugene and added to each well. Following 48 h of incubation, cells were assayed for transfection efficiency using secreted alkaline phosphatase (SEAP) with the Bright-Glo Luciferase Assay System (Promega) and then harvested and lysed using the Glo Lysis Buffer (Promega). Luciferase was assayed using Bright-Glo Luciferase Assay System and results were calculated as fold difference from the pGL3-promoter parent vector.
Tail vein plasmid DNA transfer assays. Each separate tail vein injection experiment was performed as described by Herweijer and Wolff (2003) on 3 CD1 mice using and following the TransIT Ò In Vivo Gene Delivery System Protocol (Mirus Corporation). Briefly, 10 lg of each clone, along with 2 lg of pCMVb (BD Biosciences) to correct for delivery efficiency, was injected into each mouse. Animals were sacrificed 24 h later, livers extracted, measured to correct for size, homogenized, and centrifuged for 10 min at 4000 rpm. Activity of luciferase and LacZ was measured using the Luciferase Assay System and the Galacto-Light Plus (Applied Biosystems), respectively, and quantified using the Lumat LB 9501 (Berthold).
Results
To identify potential COUP-TFII regulatory sequences, we performed comparative sequence analysis and scanned for evolutionarily conserved noncoding sequences. Initially, we compared the human COUP-TFII interval with orthologous mouse sequence and identified 2023 conserved noncoding sequences spread throughout two large gene-poor regions flanking the gene, that encompass only two genes, COUP-TFII and MGC44294 (Fig. 1A) . These include 1850-kb and 1620-kb regions upstream and downstream of the gene, respectively (Fig. 1A) .
To further prioritize these human-mouse conserved noncoding sequences for functional studies, we added a requirement for the sequence to be conserved in a more distant species. Using the available Fugu rubripes COUP-TFII genomic sequence, the number of conserved noncoding sequences in this region was reduced to three human/mouse/fugu elements based on the conventional criteria (reviewed in Ahituv et al. 2004 ) of >70% identity over >90 bp (Fig. 1B) . All three elements were located upstream of the transcription start site, with one corresponding to the known proximal promoter of the gene. Thus, two novel intervals, CNS-66kb (GenBank AY769970) and CNS-62kb (GenBank AY769971), upstream of the gene became candidates for potential gene regulatory activity based on their evolutionary conservation. Comparison between human/fugu revealed CNS66kb was 193 bp with 84% identity and CNS-62kb was 94 bp with 76% identity.
As an initial test for potential liver enhancers, we examined both elements using a luciferase reporter vector transfection assay in liver cells (HepG2). While minimal activity was found for CNS-62kb, CNS-66kb revealed six fold higher luciferase expression compared to the minimal promoter luciferase plasmid (Fig. 2) . These data suggested that human CNS-66kb could function as a liver enhancer, at least based on this in vitro assay.
To assess the ability of CNS-66kb to act as a liver enhancer in vivo, we explored naked DNA transfer of luciferase reporter vector constructs through tail vein injection of adult mice (Herweijer and Wolff 2003) . This method has been shown to deliver foreign DNA primarily to the liver as a result of the use of a large volume of injection material (10% of the mouse weight) in a very short period of time (6-8 sec) . In these experiments CNS-66kb yielded robust reporter vector expression with levels approximately 40-fold higher than the basal promoter construct and approximately eightfold higher than the well-defined ApoE liver enhancer control (Fig. 3) .
Discussion
The identification of gene regulatory elements embedded in more than 95% of the human genome which is noncoding remains a significant challenge. This is exemplified in the case of COUP-TFII, where several of the key gene regulatory elements remain undefined. The previous finding that the immediate flanking upstream sequence ()4.2 kb) of COUP-TFII failed to drive expression in liver tissue (Zhang, et al. 2002) provided support that other distant cis-regulatory elements are involved in its expression. In this study we explored the flanking COUP-TFII interval and were challenged with a large genomic search space composed of only two genes in a region which covers approximately 3500 kb, where gene regulatory sequences could reside.
While traditional deletion constructs of large genomic transgenes have identified a handful of distant regulatory sequences, the availability of several vertebrate genomes has enabled comparative genomic approaches to increasingly facilitate the identification of distant gene regulatory sequences (Boffelli et al. 2004 ). In this study based on human/mouse/ fugu evolutionary conservation, we were able to identify three conserved noncoding sequences within the approximately 3500-kb region flanking COUP-TFII. While one overlapped with the well-defined proximal promoter (Zhang et al. 2002) , two were located approximately 62 and 66 kb upstream of the gene and had not been previously described. Using two relatively rapid reporter vector construct assays, we were able to identify CNS-66kb as a putative liver enhancer; however, further experiments will be needed to demonstrate if it governs COUP-TFII liver expression or a neighboring gene(s). Interestingly, CNS-66kb showed even higher in vivo liver expression levels of a reporter gene when compared with the well-characterized and robust APOE liver enhancer (Shachter et al. 1993; Simonet et al. 1993 ). These observations warrant further investigation and suggest that this sequence may be useful to drive robust liver expression in future applications such as hepatic gene therapy or conditional gene knockouts. 
